Pharmacokinetics of Anidulafungin (Ecalta) Given Intravenously as Prophylaxis to Obese Patients With Risk of Invasive Fungal Infection Undergoing Gastric Bypass Surgery.
Phase of Trial: Phase IV
Latest Information Update: 03 May 2016
At a glance
- Drugs Anidulafungin (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- Acronyms ADOPT
- 03 May 2016 Results published in the Clinical Pharmacokinetics
- 30 Oct 2014 Last checked against the ClinicalTrials.gov record.
- 27 Oct 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.